Scopis Ent
Payments companies reported to CMS as associated with Scopis Ent. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Scopis Ent, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Scopis Ent
These are the largest totals companies reported as associated with Scopis Ent. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brian Weeks | San Diego, CA | Otolaryngology | $229,330.90 |
| Raj Sindwani | Cleveland, OH | Otolaryngology | $217,039.58 |
| Joshua Greene | Anderson, IN | Otolaryngology | $162,800.32 |
| Rodney Schlosser | Charleston, SC | Otolaryngology | $105,074.48 |
| Ayesha Khalid | Concord, MA | Otolaryngology | $88,360.11 |
| Mathew Geltzeiler | Portland, OR | Otolaryngology | $68,018.48 |
| Amber Luong | Houston, TX | Otolaryngology | $65,016.76 |
| Satyan Sreenath | Indianapolis, IN | Otolaryngology | $64,868.91 |
| Victoria Lee | Chicago, IL | Otolaryngology | $57,772.42 |
| Paul Lenkowski | Roanoke, VA | Otolaryngology | $47,150.50 |
Prescribed Scopis Ent?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.